IVF
INVO Fertility, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.04
+5.15%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.5M | 6.8M | 6.5M | 3.0M | 822.2K |
| Cost of Revenue | 5.0M | 4.3M | 3.7M | 1.9M | 850.8K |
| Gross Profit | 2.5M | 2.5M | 2.9M | 1.1M | (28.6K) |
| Operating Expenses | |||||
| R&D Expense | — | — | 489.7K | 165.9K | 544.0K |
| SG&A Expense | 8.0M | 7.7M | 9.1M | 7.5M | 10.0M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 415.9K | 677.4K | 1.4M | 200.9K | 77.3K |
| Total Operating Expenses | 8.4M | 8.4M | 11.0M | 7.9M | 10.6M |
| Cost and Expenses | 13.5M | 14.1M | 14.7M | 9.8M | 11.4M |
| Operating Income (EBIT) | (5.9M) | (5.8M) | (8.1M) | (6.8M) | (10.6M) |
| Non-Operating | |||||
| Interest Income | 139.5K | — | — | — | 308.00 |
| Interest Expense | 1.1M | 1.3M | 1.1M | 925.9K | 59.4K |
| Net Interest Income | (990.9K) | (1.3M) | (1.1M) | (925.9K) | (59.1K) |
| Other Non-Op Income/Expense | 548.9K | 1.8M | (993.3K) | (1.2M) | (263.2K) |
| Non-Operating Income (excl Interest) | 732.4K | (1.7M) | (63.1K) | 313.8K | 203.7K |
| EBT (Pre-Tax Income) | (5.4M) | (5.5M) | (9.1M) | (8.0M) | (10.9M) |
| Income Tax Expense | (94.2K) | (150.4K) | (22.9K) | 27.8K | 2.9K |
| Bottom Line | |||||
| Net Income | (5.3M) | (23.3M) | (9.1M) | (8.0M) | (10.9M) |
| Earnings from Cont. Ops | (5.3M) | (5.3M) | (9.1M) | (8.0M) | (10.9M) |
| Earnings from Discont. Ops | — | (18.0M) | — | — | — |
| Bottom Line Net Income | (7.1M) | (7.1M) | (8.0M) | (8.0M) | (10.9M) |
| Per Share | |||||
| Basic EPS | ($132.32) | ($244.04) | ($12,713.72) | ($32,336.64) | ($103,508.00) |
| Diluted EPS | ($132.64) | ($244.04) | ($12,713.72) | ($32,336.64) | ($103,508.00) |
| Revenue Per Share | $14.31 | $233.72 | $10,384.74 | $12,130.82 | $7,830.44 |
| Shares | |||||
| Basic Shares Outstanding | 526399 | 29271 | 629 | 249 | 105 |
| Diluted Shares Outstanding | 648006 | 29271 | 629 | 249 | 105 |
| Profitability Metrics | |||||
| EBITDA | (6.1M) | (3.5M) | (7.1M) | (6.9M) | (10.8M) |
| D&A | 561.4K | 677.4K | 919.6K | 200.9K | 77.3K |
| EBIT | (6.7M) | (4.2M) | (8.1M) | (7.1M) | (10.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026